Burke & Herbert Bank & Trust Co. held its stake in shares of Cigna Corporation (NYSE:CI) during the second quarter, Holdings Channel reports. The fund owned 5,038 shares of the health services provider’s stock at the end of the second quarter. Burke & Herbert Bank & Trust Co.’s holdings in Cigna Corporation were worth $843,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of the stock. NN Investment Partners Holdings N.V. raised its stake in shares of Cigna Corporation by 117.7% in the second quarter. NN Investment Partners Holdings N.V. now owns 56,955 shares of the health services provider’s stock worth $9,534,000 after buying an additional 30,795 shares in the last quarter. Pennsylvania Trust Co raised its stake in shares of Cigna Corporation by 145.3% in the second quarter. Pennsylvania Trust Co now owns 23,378 shares of the health services provider’s stock worth $3,913,000 after buying an additional 13,847 shares in the last quarter. Narwhal Capital Management raised its stake in shares of Cigna Corporation by 85.3% in the second quarter. Narwhal Capital Management now owns 19,378 shares of the health services provider’s stock worth $3,244,000 after buying an additional 8,920 shares in the last quarter. Fulton Bank N.A. raised its stake in shares of Cigna Corporation by 14.2% in the second quarter. Fulton Bank N.A. now owns 1,736 shares of the health services provider’s stock worth $291,000 after buying an additional 216 shares in the last quarter. Finally, Private Trust Co. NA raised its stake in shares of Cigna Corporation by 106.8% in the second quarter. Private Trust Co. NA now owns 2,897 shares of the health services provider’s stock worth $484,000 after buying an additional 1,496 shares in the last quarter. Hedge funds and other institutional investors own 86.87% of the company’s stock.

Cigna Corporation (NYSE CI) opened at 173.80 on Monday. Cigna Corporation has a 1-year low of $115.03 and a 1-year high of $174.27. The firm has a 50-day moving average of $164.95 and a 200-day moving average of $152.14. The stock has a market cap of $44.50 billion, a PE ratio of 23.20 and a beta of 0.46.

Cigna Corporation (NYSE:CI) last released its quarterly earnings data on Friday, May 5th. The health services provider reported $2.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.44 by $0.33. Cigna Corporation had a net margin of 6.53% and a return on equity of 16.07%. The firm had revenue of $10.39 billion for the quarter, compared to analysts’ expectations of $10.11 billion. During the same quarter last year, the business posted $2.46 earnings per share. The company’s revenue for the quarter was up 5.1% compared to the same quarter last year. Analysts expect that Cigna Corporation will post $9.78 EPS for the current fiscal year.

WARNING: This story was first reported by Watch List News and is the sole property of of Watch List News. If you are reading this story on another domain, it was stolen and reposted in violation of United States & international copyright law. The original version of this story can be accessed at https://www.watchlistnews.com/cigna-corporation-nyseci-position-maintained-by-burke-herbert-bank-trust-co/1444782.html.

Several equities analysts have recently issued reports on CI shares. Credit Suisse Group reaffirmed an “outperform” rating and set a $193.00 price target (up previously from $190.00) on shares of Cigna Corporation in a research note on Friday. Deutsche Bank AG raised their price target on shares of Cigna Corporation from $175.00 to $180.00 and gave the company a “buy” rating in a research note on Thursday. Bank of America Corporation raised their price target on shares of Cigna Corporation from $193.00 to $198.00 and gave the company a “buy” rating in a research note on Friday, June 23rd. UBS AG reissued a “buy” rating and set a $193.00 target price (up previously from $186.00) on shares of Cigna Corporation in a research note on Thursday, June 22nd. Finally, Royal Bank Of Canada lifted their target price on shares of Cigna Corporation from $177.00 to $182.00 and gave the stock an “outperform” rating in a research note on Thursday, June 22nd. Two equities research analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $176.33.

In related news, Director Jane E. Md Henney sold 600 shares of the business’s stock in a transaction on Monday, April 24th. The shares were sold at an average price of $156.92, for a total value of $94,152.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO David Cordani sold 153,168 shares of the business’s stock in a transaction on Monday, June 19th. The stock was sold at an average price of $170.20, for a total transaction of $26,069,193.60. Following the completion of the sale, the chief executive officer now owns 421,162 shares in the company, valued at approximately $71,681,772.40. The disclosure for this sale can be found here. Insiders sold 195,201 shares of company stock worth $32,862,614 in the last 90 days. 1.30% of the stock is currently owned by company insiders.

Cigna Corporation Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corporation (NYSE:CI).

Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.